The osteoporosis drug Fosamax has been linked to severe bone diseases, including femur fractures and osteonecrosis (bone death). Hundreds of people have already filed lawsuits against Merck & Co. for failing to warn about health risks of Fosamax.
Fosamax Class Action Lawsuit Information
Fosamax (alendronate) is a popular medication that is widely prescribed to older adults to prevent osteoporosis. It works by interfering with the destruction of bone. Unfortunately, bone destruction and re-growth is a normal part of maintaining healthy bones. Fosamax has been linked to a number of rare but serious bone diseases, including atypical femur fractures and Osteonecrosis of the Jaw (also known as “Dead Jaw Syndrome”).
Hundreds of people who were injured have filed lawsuits. Over 900 claims were centralized in a federal Multi-District Litigation (MDL No. 1789) in New York. In 2008, plaintiffs asked judges to certify the litigation as a class action lawsuit, but they were denied. Instead, plaintiffs have filed individual lawsuits and each lawsuit has been transferred to federal court.
Unlike a class action, each case can potentially have its own outcome. In March 2014, judges threw out lawsuits involving generic Fosamax, ruling that cases against generic drug-makers are preempted by recent Supreme Court decisions.
What is the problem?
The Clark Firm, LLP is nationally recognized as a class action law firm, but our Defective Drug Litigation Group is not filing a Fosamax class action lawsuit. Numerous lawsuits have already been filed, but they are not consolidated into a class action. Instead, we are filing individual lawsuits on behalf of people who experienced severe side effects.
- Femur fractures
- Esophagus problems (irritation, inflammation, ulcers)
- Low blood calcium levels (hypocalcemia), which can lead to muscle spasms, twitches, cramps, numbness, tingling
- Osteonecrosis (bone death) in the jaw
- Pain in bones, muscles, or joints
- And more